NantHealth, Inc. (NH): Price and Financial Metrics


NantHealth, Inc. (NH): $1.97

-0.09 (-4.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NH POWR Grades


  • Growth is the dimension where NH ranks best; there it ranks ahead of 74.53% of US stocks.
  • The strongest trend for NH is in Momentum, which has been heading down over the past 31 weeks.
  • NH's current lowest rank is in the Value metric (where it is better than 20.1% of US stocks).

NH Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for NH is -0.54 -- better than only 5.07% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -1.94 for NantHealth Inc; that's greater than it is for only 4.74% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, NantHealth Inc is reporting a growth rate of 4,307.79%; that's higher than 99.63% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to NantHealth Inc are RFP, WTM, CINF, ITMR, and ITRN.
  • Visit NH's SEC page to see the company's official filings. To visit the company's web site, go to nanthealth.com.

NH Valuation Summary

  • NH's price/sales ratio is 3.2; this is 39.62% lower than that of the median Technology stock.
  • NH's price/sales ratio has moved down 37.5 over the prior 62 months.
  • Over the past 62 months, NH's price/sales ratio has gone down 37.5.

Below are key valuation metrics over time for NH.

Stock Date P/S P/B P/E EV/EBIT
NH 2019-11-01 0.8 -2.6 -0.4 -1.7
NH 2019-06-14 0.7 -3.9 -0.3 -1.5
NH 2019-05-28 0.7 -3.8 -0.3 -1.5
NH 2018-12-27 0.6 1.1 -0.3 -1.5
NH 2018-04-09 3.9 1.7 -1.9 -2.9
NH 2017-01-06 23.8 2.8 -14.0 -14.1

NH Price Target

For more insight on analysts targets of NH, see our NH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.75 Average Broker Recommendation 1.25 (Strong Buy)

NH Stock Price Chart Interactive Chart >

Price chart for NH

NH Price/Volume Stats

Current price $1.97 52-week high $6.60
Prev. close $2.06 52-week low $1.87
Day low $1.93 Volume 111,300
Day high $2.03 Avg. volume 374,556
50-day MA $2.39 Dividend yield N/A
200-day MA $2.93 Market Cap 223.51M

NantHealth, Inc. (NH) Company Bio


NantHealth Inc. operates as a healthcare cloud-based information technology company. The Company offers a clinical platform that provide actionable health information at the point of care for critical illnesses. The company was founded in 2007 and is based in Culver City, California.


NH Latest News Stream


Event/Time News Detail
Loading, please wait...

NH Latest Social Stream


Loading social stream, please wait...

View Full NH Social Stream

Latest NH News From Around the Web

Below are the latest news stories about NantHealth Inc that investors may wish to consider to help them evaluate NH as an investment opportunity.

Where Do Hedge Funds Stand On NantHealth, Inc. (NH)?

No summary available.

Insider Monkey | June 14, 2021

NantHealth Consensus Indicates Potential 41.5% Upside

NantHealth with ticker code (NH) now have 2 analysts covering the stock with the consensus suggesting a rating of ''None''. The range between the high target price and low target price is between 4 and 3.5 calculating the average target price we see 3.75. Given that the stocks previous close was at 2.65 this now indicates there is a potential upside of 41.5%. The 50 day moving average now sits at 2.56 and the 200 moving average now moves to 3.24. The company has a market capitalisation of $303m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a softwa...

DirectorsTalk | June 11, 2021

NantHealth Consensus Indicates Potential 39.9% Upside

NantHealth with ticker code (NH) have now 2 analysts in total covering the stock. The consensus rating is ''None''. The range between the high target price and low target price is between 4 and 3.5 and has a mean target at 3.75. Given that the stocks previous close was at 2.68 this would imply there is a potential upside of 39.9%. There is a 50 day moving average of 2.54 and the 200 day MA is 3.22. The company has a market capitalisation of $304m. Company Website: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solutio...

DirectorsTalk | June 4, 2021

NantHealth Consensus Indicates Potential 51.8% Upside

NantHealth with ticker code (NH) have now 2 analysts in total covering the stock. The consensus rating is ''None''. The range between the high target price and low target price is between 4 and 3.5 with a mean TP of 3.75. Now with the previous closing price of 2.47 this would indicate that there is a potential upside of 51.8%. The day 50 moving average is 2.7 while the 200 day moving average is 3.19. The market capitalisation for the company is $285m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decisio...

DirectorsTalk | May 21, 2021

NantHealth Consensus Indicates Potential 57.6% Upside

NantHealth found using ticker (NH) have now 2 analysts covering the stock. The analyst consensus points to a rating of ''None''. The target price ranges between 4 and 3.5 calculating the mean target price we have 3.75. Given that the stocks previous close was at 2.38 this would imply there is a potential upside of 57.6%. The day 50 moving average is 2.81 and the 200 day moving average is 3.18. The company has a market cap of $255m. Company Website: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centraliz...

DirectorsTalk | May 14, 2021

Read More 'NH' Stories Here

NH Price Returns

1-mo -21.83%
3-mo -24.52%
6-mo -53.32%
1-year -50.87%
3-year -37.26%
5-year -80.50%
YTD -39.01%
2020 213.59%
2019 90.74%
2018 -82.30%
2017 -69.32%
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1288 seconds.